NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to sales ratio

Percentile
P100
Near historical high
vs 2Y Ago
3.8x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
2025156.57+331.4%
202436.29-11.4%
202340.97+1713.0%
2022-2.54-
20210.00-
20200.00-